
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **FABP3 (Fatty Acid Binding Protein 3):** Involved in fatty acid uptake, transport, and metabolism.<br>- **DHRS2 (Dehydrogenase/Reductase 2):** Functions in retinoid metabolism and may play a role in cellular differentiation.<br>- **STC2 (Stanniocalcin 2):** Involved in calcium and phosphate homeostasis.<br>- **RAMP1 (Receptor Activity Modifying Protein 1):** Modulates receptor activity, particularly in the context of the calcitonin gene-related peptide (CGRP) receptor.<br>- **MGP (Matrix Gla Protein):** Inhibits vascular calcification and is involved in bone development.<br>- **COX6C (Cytochrome c Oxidase Subunit 6C):** Part of the electron transport chain, involved in cellular respiration.<br>- **NUPR1 (Nuclear Protein 1):** A stress response protein involved in cell cycle regulation and apoptosis.<br>- **XBP1 (X-Box Binding Protein 1):** A transcription factor involved in the unfolded protein response and endoplasmic reticulum stress.<br>- **ESR1 (Estrogen Receptor 1):** A nuclear hormone receptor for estrogen, playing a critical role in breast tissue development and cancer.<br><br>### Step 2: List the Key Cell Type Markers<br>- **SCGB2A2 (Secretoglobin Family 2A Member 2):** Also known as Mammaglobin-A, a marker for mammary epithelial cells and breast cancer.<br>- **KRT19 (Keratin 19):** An intermediate filament protein, commonly expressed in epithelial cells, particularly in breast tissue.<br>- **KRT18 (Keratin 18):** Another keratin protein, often found in simple epithelial cells.<br>- **KRT8 (Keratin 8):** Expressed in simple epithelial cells, often co-expressed with KRT18.<br>- **GATA3 (GATA Binding Protein 3):** A transcription factor critical for luminal epithelial cell differentiation in the mammary gland.<br>- **ELF3 (E74 Like ETS Transcription Factor 3):** Involved in epithelial cell differentiation.<br>- **CD24:** A cell surface protein often used as a marker for epithelial and cancer stem cells.<br>- **AGR3 (Anterior Gradient 3):** Associated with epithelial cell differentiation and breast cancer.<br>- **SUSD3 (Sushi Domain Containing 3):** Expressed in breast tissue and associated with breast cancer.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and epithelial cell markers, we can confirm that many of these markers are associated with epithelial cells, particularly those of the mammary gland.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of markers such as SCGB2A2, KRT19, KRT18, KRT8, GATA3, and ESR1, the most probable general cell type is **luminal epithelial cells** of the breast. These markers are characteristic of cells that line the ducts and lobules of the mammary gland.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Progenitor Cells:** Characterized by the expression of KRT19, KRT18, and GATA3, these cells are precursors to mature luminal cells and are often implicated in breast cancer.<br>2. **Mature Luminal Cells:** Express high levels of SCGB2A2, KRT8, and ESR1, indicating differentiated luminal epithelial cells.<br>3. **Luminal Breast Cancer Cells:** Given the context of breast cancer tissue, these cells may represent cancerous luminal epithelial cells, characterized by aberrant expression of markers like ESR1 and GATA3.<br><br>The most likely subtype, based on the markers, is **Mature Luminal Cells**, given the high expression of SCGB2A2, KRT19, KRT18, and ESR1.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of key markers such as SCGB2A2, KRT19, KRT18, GATA3, and ESR1 supports this annotation. Within this general cell type, the most probable subtypes are luminal progenitor cells, mature luminal cells, and luminal breast cancer cells, with mature luminal cells being the most likely subtype.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers SCGB2A2, KRT19, KRT18, KRT8, GATA3, and ESR1 are all present in the marker list and are well-known markers for luminal epithelial cells in breast tissue.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal progenitor cells, mature luminal cells, and luminal breast cancer cells. <br>   - The analysis appropriately concludes that mature luminal cells are the most likely subtype based on the expression of key markers.<br><br>The annotation is well-supported by the marker list and the context of breast cancer tissue, and the analysis is thorough in considering potential subtypes within the luminal epithelial cell category.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Luminal Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Progenitor Cells</li><li>Mature Luminal Cells</li><li>Luminal Breast Cancer Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided for the single-cell dataset derived from human breast cancer tissue are generally well-executed, with several strengths and a few areas for improvement.<br><br>1. **Correctness of Annotations:**<br>   - The annotation correctly identifies the main cell type as luminal epithelial cells, which is consistent with the expression of key markers such as SCGB2A2, KRT19, KRT18, KRT8, GATA3, and ESR1. These markers are well-established in the literature as being indicative of luminal epithelial cells in breast tissue.<br>   - The identification of subtypes, including luminal progenitor cells, mature luminal cells, and luminal breast cancer cells, is appropriate given the context of breast cancer tissue. The emphasis on mature luminal cells as the most likely subtype is well-supported by the marker list.<br><br>2. **Balanced Consideration of Multiple Markers:**<br>   - The annotation process demonstrates a balanced consideration of multiple markers, rather than over-focusing on a single marker. The analysis includes both functional markers (e.g., FABP3, DHRS2) and cell type-specific markers (e.g., SCGB2A2, KRT19), providing a comprehensive view of the cell population.<br>   - The use of databases and literature to cross-reference and validate the marker list further strengthens the annotation's reliability.<br><br>3. **Ability to Capture the General Picture:**<br>   - The annotation captures the general picture of the cell populations present in the dataset by considering the possibility of mixed cell types and identifying potential subtypes within the luminal epithelial cell category.<br>   - The analysis is thorough and considers the rank of the markers, with key markers appearing early in the list being given appropriate weight in the final annotation.<br><br>4. **Areas for Improvement:**<br>   - While the annotation is generally accurate, it could benefit from a more detailed discussion of the potential for mixed cell types beyond the identified subtypes. This would provide a more nuanced understanding of the cell population heterogeneity.<br>   - The annotation could also explore the implications of the presence of certain functional markers (e.g., NUPR1, XBP1) in the context of breast cancer, which might offer additional insights into the cell population's behavior or state.<br><br>Overall, the annotation is scientifically accurate, well-balanced, and provides a comprehensive view of the cell types present in the dataset. It effectively captures the general picture of the cell populations, with only minor areas for improvement.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    